Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Total Debt (2016 - 2025)

Jaguar Health (JAGX) has disclosed Total Debt for 11 consecutive years, with $15.1 million as the latest value for Q4 2025.

  • Quarterly Total Debt fell 35.83% to $15.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.1 million through Dec 2025, down 35.83% year-over-year, with the annual reading at $15.1 million for FY2025, 35.83% down from the prior year.
  • Total Debt for Q4 2025 was $15.1 million at Jaguar Health, up from $7.6 million in the prior quarter.
  • The five-year high for Total Debt was $31.2 million in Q3 2023, with the low at $7.6 million in Q3 2025.
  • Average Total Debt over 5 years is $21.1 million, with a median of $21.8 million recorded in 2024.
  • The sharpest move saw Total Debt soared 5957.5% in 2021, then crashed 64.69% in 2025.
  • Over 5 years, Total Debt stood at $25.0 million in 2021, then fell by 29.09% to $17.7 million in 2022, then surged by 74.67% to $31.0 million in 2023, then fell by 24.17% to $23.5 million in 2024, then plummeted by 35.83% to $15.1 million in 2025.
  • According to Business Quant data, Total Debt over the past three periods came in at $15.1 million, $7.6 million, and $10.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.